Hyperthyroidism presents unique challenges for anesthetic management, particularly in pregnant women with Graves’ disease, who are at risk for thyroid storm—a life-threatening condition triggered by stress, infection, or surgery. Anesthesia care for hyperthyroid patients requires careful planning to prevent this dangerous condition and to mitigate cardiovascular risks associated with elevated thyroid hormone levels.
Clinical Manifestations Affecting Anesthetic Management
Hyperthyroid patients, especially those with Graves' disease, are in a hypermetabolic state that affects various organ systems. These patients often experience tachycardia, hypertension, and cardiac arrhythmias, making them vulnerable to heart failure during stressful events such as surgery. They are also more sensitive to catecholamines, which can increase their susceptibility to cardiovascular instability during the perioperative period.
Other clinical features include muscle weakness, heat intolerance, and weight loss, all of which can complicate anesthetic management. Pregnant women with hyperthyroidism are at a higher risk of preeclampsia, preterm labor, and fetal complications, including intrauterine growth restriction (IUGR) and fetal thyrotoxicosis, due to the transfer of thyroid-stimulating antibodies across the placenta.
Preoperative Management
The primary goal in managing hyperthyroid patients before surgery is to achieve a euthyroid state through antithyroid medications such as propylthiouracil (PTU) or methimazole. Beta-blockers, particularly propranolol, may also be prescribed to control hyperadrenergic symptoms like tachycardia and hypertension. In urgent surgical situations, where there may not be enough time to reach a euthyroid state, intravenous beta-blockers or magnesium can help mitigate cardiovascular risks.
If antithyroid medications alone are not sufficient, glucocorticoids such as dexamethasone can be used to inhibit the conversion of T4 to T3. Preoperative preparation should also include aspiration prophylaxis, as for every parturient; pregnancy lowers esophageal sphincter tone, and thyroid dysfunction can further disturb gastric motility. Examine the neck and airway carefully: a large goiter can deviate or compress the trachea, and positional dyspnea, stridor, or dysphagia warrants a chest radiograph or CT of the neck and a plan for awake fiberoptic intubation if tracheal compression is suspected. Exophthalmos calls for meticulous eye protection. Elective surgery is postponed until the patient is euthyroid; when thyroidectomy is needed in pregnancy, the second trimester is the preferred window.
Intraoperative Considerations
Whenever possible, regional anesthesia is preferred over general anesthesia in hyperthyroid patients. Epidural anesthesia is particularly beneficial for pregnant women, as it allows for gradual sympathetic blockade and better control of hemodynamics. Spinal anesthesia should be avoided in patients receiving high doses of beta-blockers, as it can cause exaggerated hypotension due to rapid sympathetic blockade.
When general anesthesia is required, careful cardiovascular monitoring is essential. Hyperthyroid patients are prone to tachyarrhythmias and hypertension during induction and intubation, increasing the risk of thyroid storm. Anesthetic agents that minimize sympathetic stimulation, such as propofol and volatile anesthetics, are preferred. Opioids may also be used to blunt the cardiovascular response to intubation. Avoid drugs that stimulate the sympathetic nervous system or release catecholamines: ketamine, indirect-acting vasopressors such as ephedrine, and vagolytic agents such as atropine and pancuronium can all provoke tachyarrhythmias. Phenylephrine is the preferred vasopressor for hypotension, and esmolol gives rapid, titratable rate control. MAC is not increased by hyperthyroidism itself, although hyperthermia raises anesthetic requirement, and the accelerated drug metabolism of the hypermetabolic state can shorten the action of some agents. Continuous monitoring of blood pressure, heart rate, and core temperature is critical, as hyperthyroid patients are prone to hyperthermia and cardiovascular instability.
Thyroid Storm Management
In the event of a thyroid storm, immediate intervention is critical. Treatment is given in a deliberate order. First, control the adrenergic response with a beta-blocker (propranolol 60 to 80 mg orally every 4 to 6 hours, or an esmolol infusion for titration; propranolol also blocks peripheral T4-to-T3 conversion). Second, stop new hormone synthesis with a thionamide (PTU 500 to 1,000 mg loading dose, then 250 mg every 4 hours; PTU is preferred in storm because it also blocks peripheral T4-to-T3 conversion). Third, at least one hour after the thionamide, block hormone release with iodine (saturated solution of potassium iodide 5 drops every 6 hours, or Lugol's solution 10 drops every 8 hours); given before the thionamide, iodine would instead feed new hormone synthesis. Fourth, give a glucocorticoid (hydrocortisone 300 mg IV, then 100 mg every 8 hours, or dexamethasone 2 mg every 6 hours) to reduce T4-to-T3 conversion and cover possible relative adrenal insufficiency. Treat the precipitant, and remember that delivery is not itself a treatment for storm: stabilize the mother first. Intensive care may be required, involving cooling measures (acetaminophen and external cooling; avoid salicylates, which displace T4 from binding proteins), IV fluids, and electrolyte management to stabilize the patient.
| Element | Detail |
|---|---|
| Typical triggers | Stressful events such as labor, surgery, or infection |
| Presentation | Fever, tachycardia out of proportion to fever, agitation or delirium, vomiting and diarrhea, heart failure, multi-organ failure; Burch-Wartofsky score 45 or more is highly suggestive, 25 to 44 impending, under 25 unlikely |
| Step 1: adrenergic control | Beta-blocker: propranolol 60 to 80 mg every 4 to 6 hours or an esmolol infusion |
| Step 2: antithyroid drug | Propylthiouracil (PTU) 500 to 1,000 mg loading dose, then 250 mg every 4 hours; also blocks T4 to T3 conversion |
| Step 3: iodine | SSKI 5 drops every 6 hours or Lugol’s solution 10 drops every 8 hours, given at least 1 hour after the thionamide |
| Step 4: steroids | Hydrocortisone 300 mg IV then 100 mg every 8 hours, or dexamethasone 2 mg every 6 hours; reduces T4 to T3 conversion and covers relative adrenal insufficiency |
| Supportive care | Acetaminophen and external cooling (no salicylates), IV fluids, electrolyte management, treat the precipitant; intensive care may be needed |
Postoperative Management
Close postoperative monitoring is essential for hyperthyroid patients, particularly for signs of thyroid storm if the condition was not fully controlled before surgery. Continuous cardiac monitoring should be maintained to detect arrhythmias, and beta-blockers should be continued to manage heart rate. If intraoperative glucocorticoid therapy was used, postoperative steroids may also be required. Vigilance in the immediate postoperative period is crucial to ensure the patient remains stable and avoids complications.
